WEKO3
アイテム
{"_buckets": {"deposit": "ef684493-4230-4cec-a97f-38dd21bdccc4"}, "_deposit": {"created_by": 15, "id": "5521", "owners": [15], "pid": {"revision_id": 0, "type": "depid", "value": "5521"}, "status": "published"}, "_oai": {"id": "oai:air.repo.nii.ac.jp:00005521", "sets": ["940", "922"]}, "author_link": ["15555", "15556", "15557", "14974", "15558", "15559", "15560", "5587", "10096", "8893"], "control_number": "5521", "item_10001_biblio_info_7": {"attribute_name": "書誌情報", "attribute_value_mlt": [{"bibliographicIssueDates": {"bibliographicIssueDate": "2018", "bibliographicIssueDateType": "Issued"}, "bibliographicIssueNumber": "3", "bibliographicPageStart": "882", "bibliographicVolumeNumber": "19", "bibliographic_titles": [{"bibliographic_title": "International Journal of Molecular Sciences"}]}]}, "item_10001_description_5": {"attribute_name": "内容記述(抄録)", "attribute_value_mlt": [{"subitem_description": "While tacrolimus and everolimus have common metabolic pathways through CYP3A4/5, tacrolimus is metabolized solely by CYP3A4 in recipients with the CYP3A5*3/*3. The purpose of this study was to evaluate how the area under the blood concentration-time curves (AUC) of tacrolimus could be predicted based on CYP3A5 genotype and the AUC of everolimus in renal transplant patients taking both drugs. The dose-adjusted AUC (AUC/D) of tacrolimus and everolimus were calculated at one month and one year after transplantation. Significant correlations between the AUC/D of tacrolimus and everolimus were found for patients with the CYP3A5*1 allele or CYP3A5*3/*3 at both one month and one year. At both stages, the determination coefficients were higher and the slopes of regression equations were larger for patients with CYP3A5*3/*3 compared to the CYP3A5*1 allele. A good correlation between single doses of tacrolimus and everolimus was found for CYP3A5*3/*3 patients at 1 year after transplantation (r = 0.794, p \u003c 0.001). The variability of the AUC0–24/D of tacrolimus for each CYP3A5 genotype could be predicted based on the AUC0–12/D of everolimus. Clinicians may be able to comprehensively carry out the dose adjustments of tacrolimus and everolimus based on relationship with AUCs of both drugs in each CYP3A5 genotype.", "subitem_description_type": "Other"}]}, "item_10001_publisher_8": {"attribute_name": "出版者", "attribute_value_mlt": [{"subitem_publisher": "MDPI"}]}, "item_10001_relation_14": {"attribute_name": "DOI", "attribute_value_mlt": [{"subitem_relation_type": "isIdenticalTo", "subitem_relation_type_id": {"subitem_relation_type_id_text": "10.3390/ijms19030882", "subitem_relation_type_select": "DOI"}}]}, "item_10001_relation_25": {"attribute_name": "関連リンク", "attribute_value_mlt": [{"subitem_relation_type_id": {"subitem_relation_type_id_text": "https://doi.org/10.3390/ijms19030882", "subitem_relation_type_select": "DOI"}}]}, "item_10001_rights_15": {"attribute_name": "著作権等", "attribute_value_mlt": [{"subitem_rights": "© 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/)."}]}, "item_10001_source_id_9": {"attribute_name": "ISSN", "attribute_value_mlt": [{"subitem_source_identifier": "1422-0067", "subitem_source_identifier_type": "ISSN"}]}, "item_10001_version_type_20": {"attribute_name": "著者版フラグ", "attribute_value_mlt": [{"subitem_version_resource": "http://purl.org/coar/version/c_970fb48d4fbd8a85", "subitem_version_type": "VoR"}]}, "item_creator": {"attribute_name": "著者", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "Kagaya, Hideaki"}], "nameIdentifiers": [{"nameIdentifier": "15555", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Niioka, Takenori"}], "nameIdentifiers": [{"nameIdentifier": "15556", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Saito, Mitsuru"}], "nameIdentifiers": [{"nameIdentifier": "15557", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Inoue, Takamitsu"}], "nameIdentifiers": [{"nameIdentifier": "14974", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Numakura, Kazuyuki"}], "nameIdentifiers": [{"nameIdentifier": "15558", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Yamamoto, Ryohei"}], "nameIdentifiers": [{"nameIdentifier": "15559", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Akamine, Yumiko"}], "nameIdentifiers": [{"nameIdentifier": "15560", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "HABUCHI, Tomonori"}], "nameIdentifiers": [{"nameIdentifier": "5587", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "SATOH, Shigeru"}], "nameIdentifiers": [{"nameIdentifier": "10096", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Miura, Masatomo"}], "nameIdentifiers": [{"nameIdentifier": "8893", "nameIdentifierScheme": "WEKO"}]}]}, "item_files": {"attribute_name": "ファイル情報", "attribute_type": "file", "attribute_value_mlt": [{"accessrole": "open_date", "date": [{"dateType": "Available", "dateValue": "2021-11-25"}], "displaytype": "detail", "download_preview_message": "", "file_order": 0, "filename": "byoA_2021_2.pdf", "filesize": [{"value": "1.3 MB"}], "format": "application/pdf", "future_date_message": "", "is_thumbnail": false, "licensefree": "CC BY 4.0", "licensetype": "license_free", "mimetype": "application/pdf", "size": 1300000.0, "url": {"label": "byoA_2021_2", "url": "https://air.repo.nii.ac.jp/record/5521/files/byoA_2021_2.pdf"}, "version_id": "bacde3c1-e7b8-498d-a372-496f9d18a981"}]}, "item_keyword": {"attribute_name": "キーワード", "attribute_value_mlt": [{"subitem_subject": "tacrolimus", "subitem_subject_scheme": "Other"}, {"subitem_subject": "everolimus", "subitem_subject_scheme": "Other"}, {"subitem_subject": "CYP3A5 polymorphism", "subitem_subject_scheme": "Other"}, {"subitem_subject": "renal transplantation", "subitem_subject_scheme": "Other"}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "eng"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "journal article", "resourceuri": "http://purl.org/coar/resource_type/c_6501"}]}, "item_title": "Prediction of Tacrolimus Exposure by CYP3A5 Genotype and Exposure of Co-Administered Everolimus in Japanese Renal Transplant Recipients", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "Prediction of Tacrolimus Exposure by CYP3A5 Genotype and Exposure of Co-Administered Everolimus in Japanese Renal Transplant Recipients", "subitem_title_language": "en"}]}, "item_type_id": "10001", "owner": "15", "path": ["940", "922"], "permalink_uri": "http://hdl.handle.net/10295/00005838", "pubdate": {"attribute_name": "PubDate", "attribute_value": "2021-11-25"}, "publish_date": "2021-11-25", "publish_status": "0", "recid": "5521", "relation": {}, "relation_version_is_last": true, "title": ["Prediction of Tacrolimus Exposure by CYP3A5 Genotype and Exposure of Co-Administered Everolimus in Japanese Renal Transplant Recipients"], "weko_shared_id": -1}
Prediction of Tacrolimus Exposure by CYP3A5 Genotype and Exposure of Co-Administered Everolimus in Japanese Renal Transplant Recipients
http://hdl.handle.net/10295/00005838
http://hdl.handle.net/10295/00005838f7066300-55c8-4595-affc-d8a75189129d
名前 / ファイル | ライセンス | アクション |
---|---|---|
byoA_2021_2 (1.3 MB)
|
CC BY 4.0
|
Item type | 学術雑誌論文 / Journal Article(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2021-11-25 | |||||
タイトル | ||||||
言語 | en | |||||
タイトル | Prediction of Tacrolimus Exposure by CYP3A5 Genotype and Exposure of Co-Administered Everolimus in Japanese Renal Transplant Recipients | |||||
言語 | ||||||
言語 | eng | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | tacrolimus | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | everolimus | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | CYP3A5 polymorphism | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | renal transplantation | |||||
資源タイプ | ||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_6501 | |||||
資源タイプ | journal article | |||||
著者 |
Kagaya, Hideaki
× Kagaya, Hideaki× Niioka, Takenori× Saito, Mitsuru× Inoue, Takamitsu× Numakura, Kazuyuki× Yamamoto, Ryohei× Akamine, Yumiko× HABUCHI, Tomonori× SATOH, Shigeru× Miura, Masatomo |
|||||
内容記述(抄録) | ||||||
内容記述タイプ | Other | |||||
内容記述 | While tacrolimus and everolimus have common metabolic pathways through CYP3A4/5, tacrolimus is metabolized solely by CYP3A4 in recipients with the CYP3A5*3/*3. The purpose of this study was to evaluate how the area under the blood concentration-time curves (AUC) of tacrolimus could be predicted based on CYP3A5 genotype and the AUC of everolimus in renal transplant patients taking both drugs. The dose-adjusted AUC (AUC/D) of tacrolimus and everolimus were calculated at one month and one year after transplantation. Significant correlations between the AUC/D of tacrolimus and everolimus were found for patients with the CYP3A5*1 allele or CYP3A5*3/*3 at both one month and one year. At both stages, the determination coefficients were higher and the slopes of regression equations were larger for patients with CYP3A5*3/*3 compared to the CYP3A5*1 allele. A good correlation between single doses of tacrolimus and everolimus was found for CYP3A5*3/*3 patients at 1 year after transplantation (r = 0.794, p < 0.001). The variability of the AUC0–24/D of tacrolimus for each CYP3A5 genotype could be predicted based on the AUC0–12/D of everolimus. Clinicians may be able to comprehensively carry out the dose adjustments of tacrolimus and everolimus based on relationship with AUCs of both drugs in each CYP3A5 genotype. | |||||
著者版フラグ | ||||||
出版タイプ | VoR | |||||
出版タイプResource | http://purl.org/coar/version/c_970fb48d4fbd8a85 | |||||
DOI | ||||||
関連タイプ | isIdenticalTo | |||||
識別子タイプ | DOI | |||||
関連識別子 | 10.3390/ijms19030882 | |||||
書誌情報 |
International Journal of Molecular Sciences 巻 19, 号 3, p. 882, 発行日 2018 |
|||||
ISSN | ||||||
収録物識別子タイプ | ISSN | |||||
収録物識別子 | 1422-0067 | |||||
出版者 | ||||||
出版者 | MDPI | |||||
関連リンク | ||||||
識別子タイプ | DOI | |||||
関連識別子 | https://doi.org/10.3390/ijms19030882 | |||||
著作権等 | ||||||
権利情報 | © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |